Animal-derived vaccines are vaccines developed using components obtained from animals, such as viruses or bacteria. These vaccines have been instrumental in preventing various infectious diseases in both animals and humans. Common examples include vaccines for influenza, rabies, and certain types of hepatitis. In animal-derived vaccines, the pathogen is either attenuated (weakened) or inactivated to stimulate an immune response without causing disease. These vaccines often use animal cells or tissues as a culture medium for the growth of the pathogen during the manufacturing process. Animal-derived vaccines have contributed significantly to veterinary medicine, protecting livestock and domestic animals from contagious diseases. Moreover, some human vaccines, particularly those against influenza, have historically utilized embryonated chicken eggs as a medium for virus propagation. While traditional, animal-derived vaccines are subject to ongoing advancements. Recombinant DNA technology has enabled the development of recombinant vaccines, reducing reliance on animal sources. These vaccines offer new possibilities for more precise and efficient immunization strategies. The continued exploration of innovative technologies in vaccine development is critical for improving safety, efficacy, and accessibility.
Title : A universal AI design framework and brokerage platform for democratised manufacturing of mRNA therapeutics
Duccio Medini, BioForge, United States
Title : Personalized and Precision Medicine (PPM) via biodesign-driven translational applications and upgraded business modeling to secure the human biosafety: The next-step vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Development of VSV-vector based vaccine against H5N1 avian influenza by targeting both H5N1 hemagglutinin and matrix protein 2
Zhujun Ao, University of Manitoba, Canada
Title : A novel responsive microneedle platform for reliable drug and vaccine delivery
Huanhuan Li, Queen’s University Belfast, United Kingdom
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : The promise of nanotechnology in Personalized & Precision Medicine: Nano-driven precision vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Comparative efficacy of different H9N2 avian influenza virus inactivated vaccines using some commercially available adjuvants for superior control in broilers
Ayman H M El Deeb, Cairo University, Egypt
Title : Structure-based design and development of next-generation Respiratory Syncytial Virus (RSV) vaccine
Lei Chen, Yikang Biotech Suzhou Co., Ltd, China
Title : Unmasking urban immunization inequities: A cross-sectional LQAS analysis of zero-dose drivers in slum and non-slum settings of Uttar Pradesh, India
Ashish Kumar Maurya, John Snow India, India